RxDoctor Payments Data

Nasreen Wolcott

Hercules, CANPI 1316176431

Payments from drug & device makers

$3,696in general payments, 2019–2025

Across 181 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$805
  • Pfizer$367
  • Lilly USA, LLC$340
  • Johnson & Johnson$327
  • Novartis$247
  • Arcutis Biotherapeutics, Inc.$237
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,45593%
  • Education$2417%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole132$2,145
Clobetasol Propionate39$1,537
Fluorouracil18$1,151
Doxycycline Hyclate23$837
ValacyclovirValacyclovir Hcl16$696
Triamcinolone Acetonide58$695
Betamethasone Dipropionate17$546
Fluocinonide12$409
Mupirocin33$319
Clindamycin Phosphate19$287
CiclopiroxCiclopirox Olamine11$272
Hydrocortisone30$117
Hydroxyzine Hcl15$105

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →